John Celebi Sensei Biotherapeutics CEO Rating

Sensei Biotherapeutics CEO John Celebi Bio

John Celebi has over 23 years of experience building innovative entrepreneurial biotechnology companies. Previously, Mr. Celebi served as the Chief Operating Officer of X4 Pharmaceuticals where he established and oversaw the company’s oncology business strategy. He also served as Chief Business Officer of Igenica Biotherapeutics, Inc., an immunotherapy company formed by The Column Group, 5AM Ventures, Orbimed and Third Rock Ventures, where he established key academic and industry relationships, including with MedImmune. He has extensive transactional and alliance management experience. Previously, he served as Vice President of Business Development, New Product Planning and Alliance Management at ArQule, Inc., where he played a central role in the formation of alliances with Roche, Daiichi-Sankyo, and Kyowa Hakko Kirin. Mr. Celebi was one of the early employees at Tularik, Inc., where he conducted drug discovery and basic research for an anti-viral drug program. Mr. Celebi received an M.B.A. from Carnegie Mellon University and a B.S. in Biophysics from the University of California, San Diego.

Sensei Biotherapeutics CEO John Celebi At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Sensei Biotherapeutics.

Sensei Biotherapeutics' CEO is highly regarded by the Finance department, the Executive department, and the Operations department. However, employees with 1 to 3 Years experience, the Product department, and the Engineering department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.